NeuroMetrix Inc (NURO.OQ)
NURO.OQ on NASDAQ Stock Exchange Capital Market
1.92USD
12:36pm EDT
1.92USD
12:36pm EDT
Price Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$1.92
$1.92
Open
$1.91
$1.91
Day's High
$1.95
$1.95
Day's Low
$1.90
$1.90
Volume
2,138
2,138
Avg. Vol
13,167
13,167
52-wk High
$5.04
$5.04
52-wk Low
$1.85
$1.85
About
NeuroMetrix, Inc. (NeuroMetrix) is a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes. The Company is focused on the development of products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with... (more)
Overall
| Beta: | 0.17 |
| Market Cap (Mil.): | $4.34 |
| Shares Outstanding (Mil.): | 2.26 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| NURO.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 28.54 | 32.18 |
| EPS (TTM): | -3.90 | -- | -- |
| ROI: | -82.92 | 9.72 | 18.91 |
| ROE: | -83.54 | 13.06 | 19.87 |
Competitors
| Price | Change | |
|---|---|---|
| Natus Medical Inc (BABY.OQ) | $13.92 | -0.03 |
| CareFusion Corporation (CFN.N) | $37.15 | -0.20 |
| Johnson & Johnson (JNJ.N) | $86.46 | -0.17 |
| Roche Holding Ltd. (ROG.VX) | CHF235.70 | +1.10 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: TheStreet.com Ratings
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

